COVID-19 Induced Telogen Effluvium

NCT04834102 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-04-06

No results posted yet for this study

Summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Conditions

  • Covid19
  • Telogen Effluvium
  • SARS-CoV Infection
  • Alopecia

Interventions

DIAGNOSTIC_TEST

Blood Tests

Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Principal Investigators

  • Hasan AKSOY, Dr. · Istanbul Medeniyet University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2021-04-27
Completion
2021-04-27

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834102 on ClinicalTrials.gov